Sunday, October 23, 2016
Press Releases Minimize

Rx-360 Press Releases

08-May-15: Rx-360 Creates Asia Working Group

06-January-15: Rx-360 Welcomes New Officers and Board Members

Rx-360 Announces Support of FDA’s  “Know Your Source” Initiative

07-August-14: Rx-360 Launches The “Traceability Data Exchange Architecture Work Group”

04-July-14: Rx-360 Announces the Release of the Rx-360 Supplier Assessment Questionnaire

08-July-14: Rx-360 Presents Award to FDA's Dr. Janet Woodcock for Her Service to Patients

06-June-14:  Rx-360 and BioFortis announce release of on-line pharmaceutical supplier audit tool for the Rx-360 Consortium

05-June-14: Rx-360 Selects BSI Supply Chain Solutions to Lead  Its International Joint Audit Program

20-May-14: Press Release: Rx-360 Launches Medical Device Initiative

07-Jan-14 Press Release: Rx-360 Applauds Brazil's Sao Paulo Assembly for Approving a Bill to Reduce Cargo Theft

13-Dec-13 Press Release:  Rx-360 Holds Inaugural Meeting of Asia Working Group

28-Nov-13 Press Release - Rx-360 Applauds Passage of Drug Quality and Security Act

08-OCt-13: Rx-360 to present CPhI

03-Sep-13: Rx-360 Endorses FDA’s Secure Supply Chain Pilot Program

15-May-13: Press Release - Rx-360 Launches Campaign to Educate Healthcare Community About Risks of Counterfeit and Diverted Medicine

19-April-13: Rx-360 Supports GS1 HealthCare Standards Along with 30 Other Industry Leaders

22-March-13: Rx-360 Release IPhone and Ipad Apps

14-February-13: Rx-360 Applauds the Effort of the Institute of Medicine's and Their Report on Falsified Medicines

07-February-13: Rx-360 Members Giving Back to the Community at InfomEx in Los Angeles 

24-Jan-13: Joint Rx-360- PCSC Conference Recognized Several Key Law Enforcement Officials For Their Achievements

14-Jan-13: Rx-360 Elects New Officers and Board Members

10-Oct-12: Rx-360 Alert: Projected Pork Shortage Could Lead to Shortages of Heparin & other Animal Derived Pharmaceuticals

25-Sep-12: Rx-360 is hosting a complimentary open session at CPhI in Madrid

To view or download the presentation from the press conference, click here

24-Sep-12: Rx-360 Congratulates the US Senate for Passing the Safe Doses Act & the Efforts of PSI & PCSC to Support this Accomplishment

14-Aug-12: Rx-360 to Present at CPhI in Madrid on October 10, 2012

04-Jun-12 Rx-360 Releases White paper and Tools on Audit and Assessments of Logistics Service Providers

14-May-12: Rx-360 Releases Audit Program Documents and Available Audit Reports 

03-May-12: Rx-360 Congratulates Law Enforcement for "Operation Southern Hospitality" Solving the Lilly Warehosue and other Pharmaceutical Burglaries

17-Apr-12: Rx-360 Releases White Paper on Supply Chain Security Management Systems

03-Apr-12: Joint Audit Programme is now Live

09-Mar-12: Rx-360 Applauds US Policymakers for Increasing Penalties for Stealing and Counterfeiting Pharmaceuticals

22-Nov-11: Rx-360 Partners with Habitat for Humanity at Informex 2012

18-Nov-11: Rx-360 Applauds US Policymakers for Introducing the Counterfeit Drug Penalty Enhancement Act

03-Oct-11: Rx-360 to Present at CPhI

30-Sep-11: Rx-360 Elects New Board Members and Approves Two Best Practices Documents

28-Sep-11: Rx-360 Creates New Supply Chain Working Group

20-Sep-11: Rx-360 Has Launched The Audit Sharing Program

14-Sep-11: Rx-360 Testified Before the US Senate HELP Committee - See the Video and Read the Testimony

13-Sep-11: Rx-360 Has Been Invited to Testify Before the US Senate HELP Committee on September 14, 2011

22-Jul-11: Rx-360 Shared Audit Pilot Generates Positve Results

07-Jun-11: Rx-360's Joint Audit Program Continues to Grow

13-May-11: Rx-360 Releases Points to Consider: How to Improve Security of Pharmaceutical Shipments

04-May-11: Rx-360 Conducts It's First Joint Audit

27-Oct-10: Rx-360 Publishes Audit Standards and Auditing Tools

05-Oct-10: Rx to Present at CPhI Press Conference in Paris

04-Oct-10: Rx-360 is pleased to inform that a new board of directors has been elected

24-Sep-10: Rx-360 2010 Open Meeting Draws Interested Parties from Across the Globe

16-Sep-10: U.S. Federal Trade Commission Grants Positive Advisory Opinion to Rx-360

19-Aug-10: Three Regulatory Leaders to Present at Rx-360 Open Meeting in Germany

04-Aug-10: Rx-360 Invitation to Interested Parties for September Open Meeting

21-Jun-10: Rx-360’s Guy Villax to present at Walpole Lecture Series entitled To what extent can pharmaceutical counterfeiting ever be contained?

04-Mar-10: Rx-360 Members to Start Sharing Existing Audit Data



Rx-360 News (30 March 2009) Minimize


Regulators and Pharmaceutical Industry Leaders Are Invited to Join New International Pharmaceutical Supply Chain Consortium; First Meeting in Washington, D.C. on June 5

WASHINGTON, D.C. – March 4, 2009 – The board of advisors for Rx-360 issued an open invitation today to regulators, executives of pharmaceutical and biotechnology companies and their suppliers to join this new international not-for-profit organization. Rx-360 has been formed to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain.

The consortium will be comprised primarily of proprietary and generic drug product manufacturers and their suppliers of ingredients and components. Members will hold their first meeting on June 5, 2009 at the Ronald Reagan Building and International Trade Center in Washington, D.C.

“By building this consortium and bringing together leaders from the pharmaceutical and biotechnology industries, our suppliers and regulatory agencies, we can begin to address more directly and swiftly issues critical to a safe and successful supply chain,” said Martin VanTrieste, advisory committee member and Amgen vice president, Quality, Commercial Operations. “Rx-360’s mission is simple - improve the quality, authenticity and security of the global supply chain so that all patients benefit. Patient safety should never be a competitive advantage,” VanTrieste added.

The consortium is being chartered to develop operating standards, develop technologies, share data and create a supplier audit sharing function to improve the efficiency, oversight and accountability of the global pharmaceutical supply chain. The organization will be headquartered in the Washington, D.C. area utilizing existing infrastructure of similar organizations serving other industries.

The mission of the new organization is timely in light of growing attacks and threats to an increasingly complex and global supply chain. Millions of people around the world are treated every day with the vital medicines that pharmaceutical and biotechnology companies provide. Management of the pharmaceutical supply chain has become one of the top public health concerns with respect to consumer safety. The globalization of distribution for both drug components and finished products has introduced many complications that Rx-360 is positioned to help resolve.

Unethical players and noncompliant companies along the supply chain introduce counterfeited, adulterated and contaminated materials, often with tragic consequences. Recent highly publicized events include:

  • Adulterated glycerin with diethylene glycol (antifreeze) used to manufacture cough syrup linked to 67 deaths in Panama and 103 deaths in Haiti (mostly children).
  • Adulterated heparin with hypersulfated chondroitin sulfate linked to 81 deaths in the US and Europe.
  • Adulterated milk with melamine linked to contaminated infant formula causing kidney stones and deaths of infants in China.
  • Adulterated glycerin with diethylene glycol used to manufacture teething gel linked to over 40 infant deaths in Nigeria.
  • The World Health Organization (WHO) estimates that 10% of all medicines around the world are counterfeit. In addition, it estimates that up to 30% of medicines sold in developing countries may be counterfeit, and some studies conclude that the percentage may be even higher. (www.wpro.who.int/media_centre/fact_sheets/fs_20050506.htm)

Regulators, pharmaceutical and biotechnology executives, supplier executives and members of professional organizations ultimately share a common mission, to serve patients. Legislators, regulators and professional organizations around the world are currently attempting to develop local solutions to this complex and global problem. The consortium aims to bring these independent efforts together to support a single global response.

“The time to act is now,” VanTrieste said. “Working together, we can create global quality and regulatory systems that address these threats to patient safety. I look forward to the day when we can reflect on the outcomes of our work and see that our actions made a difference in the lives of patients.”
For more information on the upcoming summit or the consortium, or to attend the summit, please go to www.rx-360.org or send an email to [email protected]




2009 © Rx-360